Haemonetics Announced The Full Market Release Of Its Vascade MVP XL Mid-bore Venous Closure System As The Newest Addition To Haemonetics' Vascade Portfolio Of Vascular Closure Systems Featuring Collapsible Disc Technology And A Proprietary Resorbable Collagen Patch To Promote Rapid Hemostasis
Portfolio Pulse from Benzinga Newsdesk
Haemonetics announced the full market release of its Vascade MVP XL Mid-bore Venous Closure System, which is the latest addition to its Vascade portfolio. The system features collapsible disc technology and a proprietary resorbable collagen patch to promote rapid hemostasis.
August 15, 2024 | 10:38 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Haemonetics has launched the Vascade MVP XL Mid-bore Venous Closure System, expanding its Vascade portfolio with advanced technology aimed at promoting rapid hemostasis.
The launch of the Vascade MVP XL Mid-bore Venous Closure System is likely to positively impact Haemonetics' stock in the short term due to the expansion of its product portfolio and the introduction of advanced technology that could drive sales and market share.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100